Inorevia is a French startup exploiting cutting-edge patented technologies to accelerate Research in Biology and Medicine. By providing researchers and clinicians with innovative tools, Inorevia aims at solving the challenge of increasing complexity in Biology.

With the advent of the multi-OMICs era, the ability to integrate genomic, transcriptomic, epigenomic and proteomic profiling highlights a clear and obvious need for miniaturization. At the core of Inorevia’s products lie patented technologies harnessing the power of microfluidics to miniaturize and automate hundreds of Biology protocols, with unprecedented results. Inorevia’s robust, intuitive and fully automated instruments will pave the way toward a new generation of solutions for Life Sciences.